000 | 01847 a2200625 4500 | ||
---|---|---|---|
005 | 20250513124554.0 | ||
264 | 0 | _c19971001 | |
008 | 199710s 0 0 eng d | ||
022 | _a0890-9016 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGiral, M | |
245 | 0 | 0 |
_aSingle-center analysis of 468 first cadaveric kidney allografts with a uniform ATG-CsA sequential therapy. _h[electronic resource] |
260 |
_bClinical transplants _c1996 |
||
300 |
_a257-64 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 |
_aAdrenal Cortex Hormones _xtherapeutic use |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAge Factors |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAnalysis of Variance |
650 | 0 | 4 |
_aAntilymphocyte Serum _xtherapeutic use |
650 | 0 | 4 |
_aAzathioprine _xtherapeutic use |
650 | 0 | 4 | _aCadaver |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 |
_aCyclosporine _xtherapeutic use |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFrance |
650 | 0 | 4 |
_aGraft Rejection _xepidemiology |
650 | 0 | 4 | _aGraft Survival |
650 | 0 | 4 | _aHistocompatibility Testing |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 |
_aKidney Transplantation _ximmunology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aMultivariate Analysis |
650 | 0 | 4 |
_aPrednisolone _xtherapeutic use |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aSex Factors |
650 | 0 | 4 | _aTissue Donors |
700 | 1 | _aTaddei, C | |
700 | 1 | _aNguyen, J M | |
700 | 1 | _aDantal, J | |
700 | 1 | _aHourmant, M | |
700 | 1 | _aCantarovich, D | |
700 | 1 | _aBlancho, G | |
700 | 1 | _aAncelet, D | |
700 | 1 | _aSoulillou, J P | |
773 | 0 |
_tClinical transplants _gp. 257-64 |
|
999 |
_c9265444 _d9265444 |